Physician
Chua, Janet
Chua, Janet was paid $1.04M by Medicaid between Jan 2018 and Mar 2023, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoCHUA, JANET
REVERE, MA 02151
REVERE, MA 02151
33aNPI1750388419assigned 07/07/2005
33bProvider typePediatrics Physician
28Total paid$1.04M
24GClaims31,684
24DCodes billed45
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#73 of 1,273
Median peer was paid$24K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,739 | $192K | |
| 2019 | 6,862 | $216K | |
| 2020 | 4,700 | $147K | |
| 2021 | 5,024 | $163K | |
| 2022 | 7,616 | $266K | |
| 2023 | 1,743 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 3,924 | 3,671 | $228K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 3,900 | 3,224 | $121K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.2% | 975 | 942 | $96K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.1% | 1,003 | 1,001 | $85K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.9% | 904 | 895 | $72K |
| 92587 | 5.5% | 1,833 | 1,814 | $58K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 689 | 689 | $58K |
| 90461 | 3.5% | 1,272 | 1,270 | $37K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.2% | 3,659 | 3,644 | $33K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 641 | 615 | $33K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.8% | 325 | 324 | $30K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.1% | 2,118 | 2,055 | $22K |
33 more codes
| 99051 | 2.0% | 1,217 | $21K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 666 | $16K |
| 99173 | 1.5% | 810 | $16K | |
| 96127 | 1.5% | 1,478 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 681 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 1,401 | $11K |
| 36416 | <1% | 661 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 390 | $10K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 111 | $9K |
| 99177 | <1% | 549 | $7K | |
| 83655 | <1% | 640 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 462 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 61 | $5K |
| 99188 | <1% | 180 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 182 | $4K |
| 99384 | <1% | 25 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 84 | $3K |
| 87081 | <1% | 306 | $2K | |
| 0072A | <1% | 35 | $2K | |
| 0071A | <1% | 30 | $1K | |
| 92552 | <1% | 50 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 103 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 38 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $1K |
| 99383 | <1% | 12 | $1K | |
| 87634 | <1% | 15 | $928.80 | |
| 87070 | <1% | 50 | $833.88 | |
| 92551 | <1% | 15 | $148.95 | |
| 81000 | <1% | 14 | $138.04 | |
| 81002 | <1% | 28 | $74.45 | |
| 94760 | <1% | 35 | $69.30 | |
| 99000 | <1% | 62 | $62.00 | |
| 85018 | <1% | 12 | $25.29 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.